NeuroFlow pricing
Nothing about cost is published: no pricing page, no unit of charge, no range, no implementation or onboarding fee position, no minimum commitment, no pilot terms and no return calculator. There is no proxy either: no cost per member, no avoided admission figure and no medical cost offset estimate appears anywhere, despite the company's entire commercial argument to a risk bearing organization being that unaddressed behavioral health comorbidity raises medical costs and damages quality metrics.
How NeuroFlow pricing works
- Pricing model
- Not disclosed. No unit of charge is described. Whether pricing is per member, per patient, per provider, per product or enterprise wide is unstated, as is how the human staffed crisis response service is charged relative to the software.
- Implementation
- Not disclosed. NeuroFlow publishes no implementation, integration or onboarding fee and no implementation timeline, although the platform requires ingestion of claims, record system, admission discharge transfer and assessment data, which is a multi feed integration effort. One published example describes a health system stratifying more than 3,000 patients within four months, which indicates time to value rather than cost.
- Business associate agreement
- Not disclosed as a template or posture. Two externally assessed credentials are stated with the qualifiers that make them assessable: health specific certification at the implemented one year tier, and a controls report at the second type, alongside stated privacy compliance. No business associate agreement template, negotiation stance or execution requirement is published. One dimension is unaddressed in published material: behavioral health information carries protection beyond general health privacy rules in the United States, and substance use disorder records fall under a separate federal confidentiality regime with distinct consent and redisclosure requirements. A platform inferring undiagnosed behavioral health conditions from population claims data sits squarely in that territory.
That argument explicitly invites a financial model and none of the inputs is supplied. The product structure makes a single pricing basis implausible and the absence therefore more consequential. Three separately named products span population analytics, integration and referral, and outcome measurement, and alongside them sits a human staffed crisis response service.
Analytics across a covered population and a staffed response line have entirely different cost structures, and nothing indicates whether they are licensed together, separately, or in tiers. The response service in particular is labor the vendor operates, which implies either volume based charging or a capacity assumption, and neither is described.
Buyer type compounds it further, since a health plan buying population analytics, a health system buying integration into primary care, and a federal department buying suicide prevention capability are three different commercial conversations. No named customer's measured medical cost offset is published.
NeuroFlow pricing against its alternatives
Published prices for NeuroFlow and the products closest to it. Each figure is as the vendor publishes it, in its own currency and billing unit.
- NNeuroFlowNo published price
- SSpring HealthNo published price
- CCanary SpeechNo published price
- GGreenspace HealthNo published price
- AAiberry$5,000/year (Digital MindCare, annual organizational license, no usage limits), with Smart AI MindCare and Custom Enterprise quoted
- AArcadia$1,275,120 per 100,000 members per 36 months (AWS Marketplace)
- AAstrataNo published price
- AArineNo published price
- XXpertDoxNot published as an amount, per claim basis stated
NeuroFlow pricing, answered
How much does NeuroFlow cost?
NeuroFlow does not publish a price. Nothing about cost is published: no pricing page, no unit of charge, no range, no implementation or onboarding fee position, no minimum commitment, no pilot terms and no return calculator.
Does NeuroFlow charge an implementation fee?
Not disclosed. NeuroFlow publishes no implementation, integration or onboarding fee and no implementation timeline, although the platform requires ingestion of claims, record system, admission discharge transfer and assessment data, which is a multi feed integration effort. One published example describes a health system stratifying more than 3,000 patients within four months, which indicates time to value rather than cost.
Does NeuroFlow offer a business associate agreement?
Not disclosed as a template or posture. Two externally assessed credentials are stated with the qualifiers that make them assessable: health specific certification at the implemented one year tier, and a controls report at the second type, alongside stated privacy compliance. No business associate agreement template, negotiation stance or execution requirement is published. One dimension is unaddressed in published material: behavioral health information carries protection beyond general health privacy rules in the United States, and substance use disorder records fall under a separate federal confidentiality regime with distinct consent and redisclosure requirements. A platform inferring undiagnosed behavioral health conditions from population claims data sits squarely in that territory.